OOIR: Observatory of International Research

Papers

(The H4-Index of British Journal of Haematology is 37. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Myeloma patients with COVID‐19 have superior antibody responses compared to patients fully vaccinated with the BNT162b2 vaccine	140
B‐cell lymphoma mimicking relapsing polychondritis	117
Lower anti‐spike levels in B‐cell‐depleted patients after convalescent plasma transfusion suggest the need for repeated doses	99
Cell erythroid maturation approach: a new paradigm in the road map towards a cure for β‐thalassaemia syndromes	85
Challenges and solutions to superior chimeric antigen receptor‐T design and deployment for B‐cell lymphomas	81
Positron emission tomography derived metrics in relapsed or refractory large B‐cell lymphoma with residual disease before autologous stem cell transplant	81
Clinicopathological characteristics and long‐term outcomes of plasmablastic lymphoma in British Columbia	75
Exome sequencing in high and low fetal haemoglobin Arab–Indian haplotype sickle cell disease	72
What complements complement in transplant‐associated thrombotic microangiopathy?	71
Safety and efficacy of a Hb‐triggered single‐unit red cell transfusion policy for haemato‐oncological inpatients	70
Long‐term outcomes of avascular necrosis in sickle cell disease using joint‐specific patient‐reported outcome measures: Results from a multicentre study	68
Clinical perspectives on post‐induction maintenance therapy in patients with acute myeloid leukaemia in remission who are ineligible for allogeneic haematopoietic stem cell transplantation	65
Burden of vaso‐occlusive crisis, its management and impact on quality of life of Indian sickle cell disease patients	65
Conditional survival of younger patients with mantle cell lymphoma: Results from a randomized phase III trial of the European MCL Network	61
Issue Information	56
Age, GVHD prophylaxis, and timing matter in thrombotic microangiopathy after haematopoietic cell transplantation—A secondary CIBMTR analysis	52
Asparagine transport through SLC1A5/ASCT2 and SLC38A5/SNAT5 is essential for BCP‐ALL cell survival and a potential therapeutic targ	52
Whole‐blood transcriptome analysis reveals distinct gene expression signatures in paediatric patients with sickle cell anaemia before and after exercise	50
MN1::ETV6‐positive de novo T‐cell acute lymphoblastic leukaemia is sensitive to venetoclax: A case report	50
Prevalence of kidney health genetic variants in adults with sickle cell nephropathy	49
Real‐world use of thrombopoietin receptor agonists for the management of immune thrombocytopenia in adult patients in the United Kingdom: Results from the TRAIT study	49
Identification of new candidate drugs in myelodysplastic syndromes with splicing factor mutations by transcriptional profiling and connectivity map analysis	48
Difficult‐to‐treat primary immune thrombocytopenia in adults: Prevalence and burden. Results from the CARMEN‐France registry	48
Outcomes of daratumumab–bortezomib–thalidomide–dexamethasone in treatment‐naive systemic AL amyloidosis	46
Zanubrutinib for the treatment of Bing–Neel syndrome	45

Clinical and molecular characteristics of paediatric mature B‐cell acute lymphocytic leukaemia and non‐Hodgkin lymphoma with bone marrow involvement: A joint study between the CCCG leukaemia and lymph	45
Low levels of minimal residual disease after induction chemotherapy for BCR‐ABL1‐negative acute lymphoblastic leukaemia in adults are clinically relevant	44
The 12‐week kinetics of anti‐SARS‐CoV‐2 antibodies in different haematological cancers after vaccination with BNT162b2	44
Risk of recurrent venous thromboembolism in patients with autoimmune diseases: data from the Registro Informatizado de Enfermedad TromboEmbólica (RIETE) registry	44
Pathogenesis, risk factors and therapeutic options for autoimmune haemolytic anaemia in the post‐transplant setting	43
Comprehensive analysis of relapsed‐refractory mature B‐cell non‐Hodgkin lymphoma in children and adolescents	42
A pilot study tracking immune cell subsets and activation profiles in adults with haemophagocytic lymphohistiocytosis treated with anakinra	42
A UK consensus algorithm for early treatment modification in newly diagnosed systemic light‐chain amyloidosis	41
Indirect presentation of mismatched human leukocyte antigen‐B associates with outcomes of cord blood transplantation	41
A safety and efficacy study of allogeneic haematopoietic stem cell transplantation for refractory and relapsed T‐cell acute lymphoblastic leukaemia/lymphoblastic lymphoma patients who achieved complet	40
Immune‐mediated thrombocytopenia and IL‐6‐mediated thrombocytosis observed in idiopathic multicentric Castleman disease	38
Van der WaltJ., OraziA., ArberD. A. (editors) Diagnostic Bone Marrow HaematopathologyCambridge, UK: Cambridge University Press, 2021. ISBN 978‐1‐107‐14 500‐9.	38
Issue Information	37
Adjunctive viral cell culture supports treatment decision‐making in patients with secondary humoral immunodeficiency and persistent SARS‐CoV‐2 infection	37